Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

GSK has had another setback in its oncology business, after the FDA asked it to restrict use of its PARP inhibitor Zejula in ovarian, fallopian tube, or primary peritoneal cancer to patients with ...

CUNY is for students at every stage of life. The university offers programs and resources for working adults, military veterans, former CUNY students, first-time college students, and near-completers.